Cargando…
Outcomes of novel coronavirus disease 2019 (COVID‐19) infection in 107 patients with cancer from Wuhan, China
BACKGROUND: Patients with cancer have a higher risk of coronavirus disease 2019 (COVID‐19) than noncancer patients. The authors conducted a multicenter retrospective study to investigate the clinical manifestations and outcomes of patients with cancer who are diagnosed with COVID‐19. METHODS: The au...
Autores principales: | Zhang, Hongyan, Wang, Linwei, Chen, Yuanyuan, Wu, Qiuji, Chen, Gaili, Shen, Xiaokun, Wang, Qun, Yan, Youqin, Yu, Yi, Zhong, Yahua, Wang, Xinghuan, Chua, Melvin L. K., Xie, Conghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361610/ https://www.ncbi.nlm.nih.gov/pubmed/32573776 http://dx.doi.org/10.1002/cncr.33042 |
Ejemplares similares
-
Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
por: Wu, Qiuji, et al.
Publicado: (2020) -
Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China
por: Xie, Conghua, et al.
Publicado: (2020) -
The impact of the COVID-19 pandemic on head and neck cancer patients
por: Chen, Gaili, et al.
Publicado: (2020) -
Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients
por: Chen, Gaili, et al.
Publicado: (2020) -
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
por: Yu, Jing, et al.
Publicado: (2020)